Flow cytometric analyses of CD34+ cells with inclusion of internal positive controlsGUTENSOHN, Kai; JESSEN, Maria; KETELS, Andrea et al.Transfusion (Philadelphia, PA). 2012, Vol 52, Num 2, pp 284-290, issn 0041-1132, 7 p.Article

Comparative genomic hybridization-aided unraveling of complex karyotypes in human hematopoietic neoplasiasVERDORFER, Irmgard; BRECEVIC, Lukrecija; SAUL, Winfried et al.Cancer genetics and cytogenetics. 2001, Vol 124, Num 1, pp 1-6, issn 0165-4608Article

Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCCREPP, Roland; KELLNER, Christian; VAN DE WINKEL, Jan G. J et al.Journal of immunological methods. 2011, Vol 373, Num 1-2, pp 67-78, issn 0022-1759, 12 p.Article

Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trialRUUTU, Tapani; VOLIN, Liisa; BLAU, Igor W et al.Haematologica (Roma). 2011, Vol 96, Num 9, pp 1344-1350, issn 0390-6078, 7 p.Article

Functional significance of novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) for human myeloma cell growth and survivalBURGER, Renate; BAKKER, Frank; GRAMATZKI, Martin et al.British journal of haematology. 2003, Vol 123, Num 5, pp 869-878, issn 0007-1048, 10 p.Article

Novel Bispecific Antibodies Increase γδ T-Cell Cytotoxicity against Pancreatic Cancer CellsOBERG, Hans-Heinrich; PEIPP, Matthias; WEISNER, Dietrich et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 5, pp 1349-1360, issn 0008-5472, 12 p.Article

Second Allograft for Hematologic Relapse of Acute Leukemia After First Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors: The Role of Donor ChangeCHRISTOPEIT, Maximilian; KUSS, Oliver; TISCHER, Johanna et al.Journal of clinical oncology. 2013, Vol 31, Num 26, pp 3259-3271, issn 0732-183X, 13 p.Article

Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibitionMEISTER, Silke; SCHUBERT, Ulrich; JÄCK, Hans-Martin et al.Cancer research (Baltimore). 2007, Vol 67, Num 4, pp 1783-1792, issn 0008-5472, 10 p.Article

Interleukin-6-dependent survival of multiple myeloma cells involves the stat3-mediated induction of microRNA-21 through a highly conserved enhancer. CommentaryHURT, Elaine M; FARRAR, William L; BLUMERT, Conny et al.Blood. 2007, Vol 110, Num 4, issn 0006-4971, 1086-1087, 1330-1333 [6 p.]Article

Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)PALUMBO, Antonio; BRINGHEN, Sara; ZWEEGMAN, Sonja et al.Blood. 2011, Vol 118, Num 17, pp 4519-4529, issn 0006-4971, 11 p.Article

Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphomaD'AMORE, Francesco; RADFORD, John; HAGBERG, Hans et al.British journal of haematology. 2010, Vol 150, Num 5, pp 565-573, issn 0007-1048, 9 p.Article

Cryopreservation of cellular products in a closed-bag system with an incorporated dimethyl sulfoxide-resistant sterile filter outside of cleanroom facilitiesHUMPE, Andreas; JANSEN, Pal; TISCHER, Bernd Karsten et al.Transfusion (Philadelphia, PA). 2007, Vol 47, Num 6, pp 1033-1041, issn 0041-1132, 9 p.Article

Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7BREMER, Edwin; SAMPLONIUS, Douwe F; PEIPP, Matthias et al.Cancer research (Baltimore). 2005, Vol 65, Num 8, pp 3380-3388, issn 0008-5472, 9 p.Article

Radiotherapy for stage I-III nodal low-grade non-Hodgkin's lymphomaOTT, Oliver J; RÖDEL, Claus; GRAMATZKI, Martin et al.Strahlentherapie und Onkologie. 2003, Vol 179, Num 10, pp 694-701, issn 0179-7158, 8 p.Article

The bisphosphonate zoledronic acid has antimyeloma activity in vivo by inhibition of protein prenylationGUENTHER, Andreas; GORDON, Sharon; TIEMANN, Markus et al.International journal of cancer (Print). 2010, Vol 126, Num 1, pp 239-246, issn 0020-7136, 8 p.Article

Reduced-Intensity Conditioning Compared With Conventional Allogeneic Stem-Cell Transplantation in Relapsed or Refractory Hodgkin's Lymphoma : An Analysis From the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationSUREDA, Anna; ROBINSON, Stephen; GRAMATZKI, Martin et al.Journal of clinical oncology. 2008, Vol 26, Num 3, pp 455-462, issn 0732-183X, 8 p.Article

Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia : Results of a phase II trialELTER, Thomas; BORCHMANN, Peter; RECH, Jurgen et al.Journal of clinical oncology. 2005, Vol 23, Num 28, pp 7024-7031, issn 0732-183X, 8 p.Article

Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activationBROCKE-HEIDRICH, Katja; KRETZSCHMAR, Antje K; PFEIFER, Gabriele et al.Blood. 2004, Vol 103, Num 1, pp 242-251, issn 0006-4971, 10 p.Article

Anti-CD20 monoclonal antibody treatment of Epstein-Barr virus-induced intrahepatic lymphoproliferative disorder following liver transplantationYEDIBELA, Süleyman; RECK, Thomas; NIEDOBITEK, Gerald et al.Transplant international. 2003, Vol 16, Num 3, pp 197-201, issn 0934-0874, 5 p.Article

A recombinant CD7-specific single-chain immunotoxin is a potent inducer of apoptosis in acute leukemic T cellsPEIPP, Matthias; KIIPERS, Heide; SAUL, Domenica et al.Cancer research (Baltimore). 2002, Vol 62, Num 10, pp 2848-2855, issn 0008-5472Article

Enhanced killing of B lymphoma cells by granulocyte colony-stimulating factor-primed effector cells and Hu1D10: a humanized human leucocyte antigen DR antibodySTOCKMEYER, Bernhard; SCHILLER, Martin; REAP, Roland et al.British journal of haematology. 2002, Vol 118, Num 4, pp 959-967, issn 0007-1048Article

Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killingDECHANT, Michael; VIDARSSON, Gestur; STOCKMEYER, Bernhard et al.Blood. 2002, Vol 100, Num 13, pp 4574-4580, issn 0006-4971, 7 p.Article

The IL-6 receptor antagonist SANT-7 overcomes bone marrow stromal cell-mediated drug resistance of multiple myeloma cellsHÖNEMANN, Dirk; CHATTERJEE, Manik; SAVINO, Rocco et al.International journal of cancer. 2001, Vol 93, Num 5, pp 674-680, issn 0020-7136Article

Mechanisms of G-CSF- or GM-CSF-stimulated tumor cell killing by Fc receptor-directed bispecific antibodiesSTOCKMEYER, Bernhard; ELSÄSSER, David; DECHANT, Michael et al.Journal of immunological methods. 2001, Vol 248, Num 1-2, pp 103-111, issn 0022-1759Article